Petra Baum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Petra Baum has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Joanna Kosacka
Department of Medicine, University of Leipzig, Liebigstraße 21, D-04103 Leipzig, Germany
3 shared publications - Klaus V. Toyka
Department of Neurology, University of Würzburg, Germany, Josef Schneider Str.11, 97080 Würzburg, Germany
3 shared publications - Marcin Nowicki
Institute of Anatomy, University of Leipzig, Liebigstraße 13, D-04103 Leipzig, Germany
3 shared publications - Matthias Blüher
Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany
3 shared publications Joanna Kosacka
Department of Neurology, University of Leipzig, Leipzig, Germany
2 shared publications- Joseph Classen
Department of Neurology, University of Leipzig Medical Center, Leipzig, Germany
2 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by Springer Nature in Neurological Research and Practice
- Vol. 8 (1) , 20
Targeting risk factors and strategies for prevention of peripheral neuropathy: focus on B-vitamin deficiencies and metabolic diseases
Background: Polyneuropathy (PN) is a common neurological disorder characterized by sensory, motor, and autonomic dysfunction of peripheral nerves. Its incidence is increasing, especially among the elderly population, making PN a significant and growing public health concern worldwide. Main body: This review highlights the key risk factors contributing to the development of PN, with a particular focus on nutritional and metabolic etiologies. These include B-vitamin deficiencies, prediabetes, diabetes mellitus, obesity, and treatment-induced neuropathies. The complex interplay of these factors often exacerbates the progression of PN and complicates management. Current preventive approaches and challenges in early detection are also discussed to provide a comprehensive overview of strategies aimed at reducing the disease burden. Conclusion: The rising prevalence and disabling nature of PN necessitate urgent public awareness, better screening, and increased healthcare resources. Advancing prevention strategies targeting modifiable risk factors may significantly reduce the impact of PN on patients and healthcare systems alike.
- 1 April 2026
- Published by Springer Nature in Neurological Research and Practice
- Vol. 8 (1) , 20
Open AccessTargeting risk factors and strategies for prevention of peripheral neuropathy: focus on B-vitamin deficiencies and metabolic diseases
Background: Polyneuropathy (PN) is a common neurological disorder characterized by sensory, motor, and autonomic dysfunction of peripheral nerves. Its incidence is increasing, especially among the elderly population, making PN a significant and growing public health concern worldwide. Main body: This review highlights the key risk factors contributing to the development of PN, with a particular focus on nutritional and metabolic etiologies. These include B-vitamin deficiencies, prediabetes, diabetes mellitus, obesity, and treatment-induced neuropathies. The complex interplay of these factors often exacerbates the progression of PN and complicates management. Current preventive approaches and challenges in early detection are also discussed to provide a comprehensive overview of strategies aimed at reducing the disease burden. Conclusion: The rising prevalence and disabling nature of PN necessitate urgent public awareness, better screening, and increased healthcare resources. Advancing prevention strategies targeting modifiable risk factors may significantly reduce the impact of PN on patients and healthcare systems alike.
- 14 March 2023
- Published by Georg Thieme Verlag KG in Klinische Neurophysiologie
- Vol. 54 (01) , 35-46
Muskelzuckungen und Muskelkrämpfe – Differenzialdiagnosen und elektrophysiologische Diagnostik
Muskelzuckungen und -krämpfe sind Beschwerden, die vom harmlosen Symptom bis hin zu Symptomen einer schwerwiegenden neurologischen Erkrankung reichen können. Eine ausführliche Anamnese, gründliche neurologische Untersuchung und elektrophysiologische Untersuchungen ermöglichen die Unterscheidung der verschiedenen Ätiologien. In diesem Artikel werden verschiedene Ursachen unter Berücksichtigung deren Definition, der elektrophysiologisch zugrunde liegenden Phänomene und deren differenzialdiagnostischer Einordnung dargestellt.
- 14 March 2023
- Published by Georg Thieme Verlag KG in Klinische Neurophysiologie
- Vol. 54 (01) , 35-46
Muskelzuckungen und Muskelkrämpfe – Differenzialdiagnosen und elektrophysiologische Diagnostik
Muskelzuckungen und -krämpfe sind Beschwerden, die vom harmlosen Symptom bis hin zu Symptomen einer schwerwiegenden neurologischen Erkrankung reichen können. Eine ausführliche Anamnese, gründliche neurologische Untersuchung und elektrophysiologische Untersuchungen ermöglichen die Unterscheidung der verschiedenen Ätiologien. In diesem Artikel werden verschiedene Ursachen unter Berücksichtigung deren Definition, der elektrophysiologisch zugrunde liegenden Phänomene und deren differenzialdiagnostischer Einordnung dargestellt.
- 17 August 2022
- Published by Elsevier in Clinical Neurophysiology
- Vol. 142, 244-253
Temporary reversal of nerve and muscle dysfunction by serial electrical stimulation in critical illness neuromyopathy
- 17 August 2022
- Published by Elsevier in Clinical Neurophysiology
- Vol. 142, 244-253
Temporary reversal of nerve and muscle dysfunction by serial electrical stimulation in critical illness neuromyopathy
- Open Access
- 1 August 2022
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Vol. 24 (3-4) , 175-184
Remote digital assessment of amyotrophic lateral sclerosis functional rating scale – a multicenter observational study
Objective: Remote self-assessment of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R) using digital data capture was investigated for its feasibility as an add-on to ALSFRS-R assessments during multidisciplinary clinic visits. Methods: From August 2017 to December 2021, at 12 ALS centers in Germany, an observational study on remote assessment of the ALSFRS-R was performed. In addition to the assessment of ALSFRS-R during clinic visits, patients were offered a digital self-assessment of the ALSFRS-R – either on a computer or on a mobile application (“ALS-App”). Results: An estimated multicenter cohort of 4,670 ALS patients received care at participating ALS centers. Of these patients, 971 remotely submitted the ALSFRS-R, representing 21% of the multicenter cohort. Of those who opted for remote assessment, 53.7% (n = 521) completed a minimum of 4 ALSFRS-R per year with a mean number of 10.9 assessments per year. Different assessment frequencies were found for patients using a computer (7.9 per year, n = 857) and mobile app (14.6 per year, n = 234). Patients doing remote assessments were more likely to be male and less functionally impaired but many patients with severe disability managed to complete it themselves or with a caregiver (35% of remote ALSFRS-R cohort in King’s Stage 4). Conclusions: In a dedicated ALS center setting remote digital self-assessment of ALSFRS-R can provide substantial data which is complementary and potentially an alternative to clinic assessments and could be used for research purposes and person-level patient management. Addressing barriers relating to patient uptake and adherence are key to its success.
- 1 August 2022
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Vol. 24 (3-4) , 175-184
Open AccessRemote digital assessment of amyotrophic lateral sclerosis functional rating scale – a multicenter observational study
Objective: Remote self-assessment of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R) using digital data capture was investigated for its feasibility as an add-on to ALSFRS-R assessments during multidisciplinary clinic visits. Methods: From August 2017 to December 2021, at 12 ALS centers in Germany, an observational study on remote assessment of the ALSFRS-R was performed. In addition to the assessment of ALSFRS-R during clinic visits, patients were offered a digital self-assessment of the ALSFRS-R – either on a computer or on a mobile application (“ALS-App”). Results: An estimated multicenter cohort of 4,670 ALS patients received care at participating ALS centers. Of these patients, 971 remotely submitted the ALSFRS-R, representing 21% of the multicenter cohort. Of those who opted for remote assessment, 53.7% (n = 521) completed a minimum of 4 ALSFRS-R per year with a mean number of 10.9 assessments per year. Different assessment frequencies were found for patients using a computer (7.9 per year, n = 857) and mobile app (14.6 per year, n = 234). Patients doing remote assessments were more likely to be male and less functionally impaired but many patients with severe disability managed to complete it themselves or with a caregiver (35% of remote ALSFRS-R cohort in King’s Stage 4). Conclusions: In a dedicated ALS center setting remote digital self-assessment of ALSFRS-R can provide substantial data which is complementary and potentially an alternative to clinic assessments and could be used for research purposes and person-level patient management. Addressing barriers relating to patient uptake and adherence are key to its success.
- Open Access
- 3 March 2022
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 14 (1) , 1-5
Functional predictors of treatment induced diabetic neuropathy (TIND): a prospective pilot study using clinical and neurophysiological functional tests
Background: A treatment-induced drop in HbA1c has been suggested to be a risk factor for TIND. Methods: From 60 included patients with severe diabetes mellitus (HbA1c over 8.5) only 21 patients adhered to the study protocol over 1 year with a battery of autonomic nervous system tests scheduled before and after starting antidiabetic treatment. Results: In patients with a drop of HbA1c greater than 2 per cent points only some neurophysiologic tests and lab values tended to deteriorate with a trend to improve at later time points along the study. None of these changes were statistically significant, most likely because the study failed to reach the planned number of patients. Conclusion: Poor adherence to diabetes treatment and to following the study protocol were the assumed obstacles in our patient cohort selected for very high HbA1c levels. In future studies a multi-center trial and case numbers of up to 500 patients may be needed to account for drop outs in the range observed here. Moreover, the number of tests in each patient at each visit may have to be reduced and special educational group sessions are warranted to cope with the limited adherence. Trial registration Ethic Committee University of Leipzig 439/15-ek. Registered 22 April 2016
- 3 March 2022
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 14 (1) , 1-5
Open AccessFunctional predictors of treatment induced diabetic neuropathy (TIND): a prospective pilot study using clinical and neurophysiological functional tests
Background: A treatment-induced drop in HbA1c has been suggested to be a risk factor for TIND. Methods: From 60 included patients with severe diabetes mellitus (HbA1c over 8.5) only 21 patients adhered to the study protocol over 1 year with a battery of autonomic nervous system tests scheduled before and after starting antidiabetic treatment. Results: In patients with a drop of HbA1c greater than 2 per cent points only some neurophysiologic tests and lab values tended to deteriorate with a trend to improve at later time points along the study. None of these changes were statistically significant, most likely because the study failed to reach the planned number of patients. Conclusion: Poor adherence to diabetes treatment and to following the study protocol were the assumed obstacles in our patient cohort selected for very high HbA1c levels. In future studies a multi-center trial and case numbers of up to 500 patients may be needed to account for drop outs in the range observed here. Moreover, the number of tests in each patient at each visit may have to be reduced and special educational group sessions are warranted to cope with the limited adherence. Trial registration Ethic Committee University of Leipzig 439/15-ek. Registered 22 April 2016
- Top Cited PapersOpen Access
- 7 October 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (19) , 10835
Inflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)—New Aspects
The pathogenesis of diabetic neuropathy is complex, and various pathogenic pathways have been proposed. A better understanding of the pathophysiology is warranted for developing novel therapeutic strategies. Here, we summarize recent evidence from experiments using animal models of type 1 and type 2 diabetes showing that low-grade intraneural inflammation is a facet of diabetic neuropathy. Our experimental data suggest that these mild inflammatory processes are a likely common terminal pathway in diabetic neuropathy associated with the degeneration of intraepidermal nerve fibers. In contrast to earlier reports claiming toxic effects of high-iron content, we found the opposite, i.e., nutritional iron deficiency caused low-grade inflammation and fiber degeneration while in normal or high non-heme iron nutrition no or only extremely mild inflammatory signs were identified in nerve tissue. Obesity and dyslipidemia also appear to trigger mild inflammation of peripheral nerves, associated with neuropathy even in the absence of overt diabetes mellitus. Our finding may be the experimental analog of recent observations identifying systemic proinflammatory activity in human sensorimotor diabetic neuropathy. In a rat model of type 1 diabetes, a mild neuropathy with inflammatory components could be induced by insulin treatment causing an abrupt reduction in HbA1c. This is in line with observations in patients with severe diabetes developing a small fiber neuropathy upon treatment-induced rapid HbA1c reduction. If the inflammatory pathogenesis could be further substantiated by data from human tissues and intervention studies, anti-inflammatory compounds with different modes of action may become candidates for the treatment or prevention of diabetic neuropathy.
- 7 October 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (19) , 10835
Top Cited PapersOpen AccessInflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)—New Aspects
The pathogenesis of diabetic neuropathy is complex, and various pathogenic pathways have been proposed. A better understanding of the pathophysiology is warranted for developing novel therapeutic strategies. Here, we summarize recent evidence from experiments using animal models of type 1 and type 2 diabetes showing that low-grade intraneural inflammation is a facet of diabetic neuropathy. Our experimental data suggest that these mild inflammatory processes are a likely common terminal pathway in diabetic neuropathy associated with the degeneration of intraepidermal nerve fibers. In contrast to earlier reports claiming toxic effects of high-iron content, we found the opposite, i.e., nutritional iron deficiency caused low-grade inflammation and fiber degeneration while in normal or high non-heme iron nutrition no or only extremely mild inflammatory signs were identified in nerve tissue. Obesity and dyslipidemia also appear to trigger mild inflammation of peripheral nerves, associated with neuropathy even in the absence of overt diabetes mellitus. Our finding may be the experimental analog of recent observations identifying systemic proinflammatory activity in human sensorimotor diabetic neuropathy. In a rat model of type 1 diabetes, a mild neuropathy with inflammatory components could be induced by insulin treatment causing an abrupt reduction in HbA1c. This is in line with observations in patients with severe diabetes developing a small fiber neuropathy upon treatment-induced rapid HbA1c reduction. If the inflammatory pathogenesis could be further substantiated by data from human tissues and intervention studies, anti-inflammatory compounds with different modes of action may become candidates for the treatment or prevention of diabetic neuropathy.
- Open Access
- 4 February 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (4) , 1571
Treatment-Induced Neuropathy in Diabetes (TIND)—Developing a Disease Model in Type 1 Diabetic Rats
Treatment-induced neuropathy in diabetes (TIND) is defined by the occurrence of an acute neuropathy within 8 weeks of an abrupt decrease in glycated hemoglobin-A1c (HbA1c). The underlying pathogenic mechanisms are still incompletely understood with only one mouse model being explored to date. The aim of this study was to further explore the hypothesis that an abrupt insulin-induced fall in HbA1c may be the prime causal factor of developing TIND. BB/OKL (bio breeding/OKL, Ottawa Karlsburg Leipzig) diabetic rats were randomized in three groups, receiving insulin treatment by implanted subcutaneous osmotic insulin pumps for 3 months, as follows: Group one received 2 units per day; group two 1 unit per day: and group three 1 unit per day in the first month, followed by 2 units per day in the last two months. We serially examined blood glucose and HbA1c levels, motor- and sensory/mixed afferent conduction velocities (mNCV and csNCV) and peripheral nerve morphology, including intraepidermal nerve fiber density and numbers of Iba-1 (ionized calcium binding adaptor molecule 1) positive macrophages in the sciatic nerve. Only in BB/OKL rats of group three, with a rapid decrease in HbA1c of more than 2%, did we find a significant decrease in mNCV in sciatic nerves (81% of initial values) after three months of treatment as compared to those group three rats with a less marked decrease in HbA1c 2% (csNCV 90% of initial values), compared to those rats with a mild decrease 2% showed significantly greater infiltration of macrophages by about 50% (p ≤ 0.01) and a decreased amount of calcitonin gene related peptide (CGRP) positive nerve fibers as compared to the animals with a milder decrease in HbA1c. We conclude that a mild acute neuropathy with inflammatory components was induced in BB/OKL rats as a consequence of an abrupt decrease in HbA1c caused by high-dose insulin treatment. This experimentally induced neuropathy shares some features with TIND in humans and may be further explored in studies into the pathogenesis and treatment of TIND.
- 4 February 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (4) , 1571
Open AccessTreatment-Induced Neuropathy in Diabetes (TIND)—Developing a Disease Model in Type 1 Diabetic Rats
Treatment-induced neuropathy in diabetes (TIND) is defined by the occurrence of an acute neuropathy within 8 weeks of an abrupt decrease in glycated hemoglobin-A1c (HbA1c). The underlying pathogenic mechanisms are still incompletely understood with only one mouse model being explored to date. The aim of this study was to further explore the hypothesis that an abrupt insulin-induced fall in HbA1c may be the prime causal factor of developing TIND. BB/OKL (bio breeding/OKL, Ottawa Karlsburg Leipzig) diabetic rats were randomized in three groups, receiving insulin treatment by implanted subcutaneous osmotic insulin pumps for 3 months, as follows: Group one received 2 units per day; group two 1 unit per day: and group three 1 unit per day in the first month, followed by 2 units per day in the last two months. We serially examined blood glucose and HbA1c levels, motor- and sensory/mixed afferent conduction velocities (mNCV and csNCV) and peripheral nerve morphology, including intraepidermal nerve fiber density and numbers of Iba-1 (ionized calcium binding adaptor molecule 1) positive macrophages in the sciatic nerve. Only in BB/OKL rats of group three, with a rapid decrease in HbA1c of more than 2%, did we find a significant decrease in mNCV in sciatic nerves (81% of initial values) after three months of treatment as compared to those group three rats with a less marked decrease in HbA1c 2% (csNCV 90% of initial values), compared to those rats with a mild decrease 2% showed significantly greater infiltration of macrophages by about 50% (p ≤ 0.01) and a decreased amount of calcitonin gene related peptide (CGRP) positive nerve fibers as compared to the animals with a milder decrease in HbA1c. We conclude that a mild acute neuropathy with inflammatory components was induced in BB/OKL rats as a consequence of an abrupt decrease in HbA1c caused by high-dose insulin treatment. This experimentally induced neuropathy shares some features with TIND in humans and may be further explored in studies into the pathogenesis and treatment of TIND.
- 1 September 2020
- Published by Georg Thieme Verlag KG in Klinische Neurophysiologie
- Vol. 51 (03) , 174-177
Motor neurography Failure
Die motorische Neurografie ist neben der sensiblen Neurografie und der Elektromyografie eine wichtige Methode in der Abklarung von neuromuskularen Erkrankungen. Gut abgeleitete, reproduzierbare Potenziale sind die Voraussetzung fur die richtige Befundung und Interpretation im Kontext mit dem klinisch neurologischen Befund. Haufige Fehler kommen sowohl bei der Stimulation als auch bei der Ableitung uber innervierten Muskeln und durch fehlenden oder fehlerhaften Einsatz der Erdelektrode vor. Weitere Fehler konnen bei der Bezeichnung und Messung der Potenziale auftreten. In dem Beitrag werden wichtige Fehler erklart und die Ursachenbehebung besprochen.
- 1 September 2020
- Published by Georg Thieme Verlag KG in Klinische Neurophysiologie
- Vol. 51 (03) , 174-177
Motor neurography Failure
Die motorische Neurografie ist neben der sensiblen Neurografie und der Elektromyografie eine wichtige Methode in der Abklarung von neuromuskularen Erkrankungen. Gut abgeleitete, reproduzierbare Potenziale sind die Voraussetzung fur die richtige Befundung und Interpretation im Kontext mit dem klinisch neurologischen Befund. Haufige Fehler kommen sowohl bei der Stimulation als auch bei der Ableitung uber innervierten Muskeln und durch fehlenden oder fehlerhaften Einsatz der Erdelektrode vor. Weitere Fehler konnen bei der Bezeichnung und Messung der Potenziale auftreten. In dem Beitrag werden wichtige Fehler erklart und die Ursachenbehebung besprochen.
- 15 October 2019
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 27 (1) , e28-e29
A Primary Myopathy Complicating Long-lasting Polymyalgia Rheumatica
- 15 October 2019
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 27 (1) , e28-e29
A Primary Myopathy Complicating Long-lasting Polymyalgia Rheumatica
- 24 April 2019
- Published by Springer Nature in Der Diabetologe
- Vol. 15 (7) , 628-635
Pathophysiologie der diabetischen Neuropathie (DN), Rolle von Entzündung und Eisenstoffwechsel
- 24 April 2019
- Published by Springer Nature in Der Diabetologe
- Vol. 15 (7) , 628-635
Pathophysiologie der diabetischen Neuropathie (DN), Rolle von Entzündung und Eisenstoffwechsel